Search results for: 'oriented medicine'

Healthcare is rapidly becoming patient-centric, focusing on outcomes and value. This offers clinical diagnostics players opportunities to advance their instrument, assay, and informatics capabilities to address unmet clinical needs and increase the precision diagnostics portfolio. Advances in next-generation sequencing-based companion diagnosti...

23 Aug 2022  |  North America  |  Frost Radar

Frost Radar™: US Liquid Biopsy, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

The oncology space is maturing rapidly. With the arrival of blood-based assays for cancer screening and the emphasis on early detection, the liquid biopsy segment is seeing increased consolidation and high-impact acquisitions, such as Illumina and GRAIL, Exact Sciences and Thrive Earlier Detection, and Roche Foundation Medicine and Lexent Bio. Comp...

07 May 2025  |  Global  |  Technology Research

Emerging Opportunities In Nanomanufacturing

Emerging Trends and Technologies in Nanotechnology-enabled Imaging, Tissue Regeneration, Drug Delivery, and Diagnostics

Infographics

×

Nanotechnology is a disruptive force in healthcare, allowing for revolutionary breakthroughs in medication administration, imaging, tissue regeneration, and diagnostics. Emerging technologies are increasingly game-changing inventions with the potential to propel industry expansion, including biodegradable nanoparticles for diagnostics, AI-powered n...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights into recent advancements across small molecules and biologics for cancer treatment. The research also covers innovations for the diagnosis and management of neurological disorders, apart from provide insights for the management of immunological...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent developments in female contraception technique, small molecule drugs, cell and gene therapies, cancer diagnosis and treatment and nanobody technologies. The research also encompasses emerging innovations across infectious and immu...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent technology advances across cell & gene therapies, immunotherapies, intelligent drug discovery approaches, automated biomanufacturing and microbiome sciences. The TOE also encompasses recent developments in proteomics, drug deliver...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides innovation insights across cell and gene therapy advances. The TOE also encompasses recent therapy developments for neuropsychiatric, rare, and infectious diseases. The research covers recent advances in vaccines and biomanufacturing platforms.The Life ...

AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, presenting opportunities for innovation. There has been a...

24 Jun 2024  |  Global  |  Market Research

Growth Opportunities in the Continuous Insulation Space

Rising Urbanization, Regulations, and Sustainability Imperatives Create Demand and Drive Industry Expansion

Infographics

×

In this analysis, Frost & Sullivan covers external insulation finishing systems (EIFS) and structural insulated panels (SIPs). For both products, we analyzed regional and global volumes and revenues, residential and nonresidential volumes, pros and cons, leading companies, and growth drivers and restraints. We also provided deeper qualitative analy...